• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pharm-Olam Growth at Record Pace in 2007

Pharm-Olam Growth at Record Pace in 2007

January 24, 2008
CenterWatch Staff

Houston-based contract research organization (CRO) Pharm-Olam International reported record revenue growth in 2007, signing $100 million in new contracts signed in the 12 months.

According to Iain Gordon, vice president of global business development at Pharm-Olam, the company saw increased demand for its data management and biostatistics services. He attributed much of company’s revenue growth to that demand.

The company also reported record geographic coverage and services additions. It established regional offices in Princeton, N.J. and Novosibirsk, Russia in 2007.

“Our global coverage continues to grow, however, our decentralized business model remains the same, allowing us to start studies quickly and manage them efficiently”, said Gordon.

In the past three years, the company has been expanding its international presence at a rapid pace. It has more than 20 offices in 40 countries across North America, Western Europe, Central and Eastern Europe, Latin America, Asia, and Africa. In June, Pharm-Olam announced plans to expand its Latin American presence by opening offices in São Paulo, Brazil and Buenos Aires, Argentina. The company also has a presence in Mexico City.

In August 2006, the company expanded its India operations and tripled its staff there. In late 2006, it opened a new office in Pretoria, South Africa.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing